Boc-GABA-OH

CAS No. 57294-38-9

Boc-GABA-OH( —— )

Catalog No. M26914 CAS No. 57294-38-9

Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Boc-GABA-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.
  • Description
    Boc-GABA-OH is a PROTAC linker that can be used to synthesize UNC6852, an EED-targeted PROTAC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57294-38-9
  • Formula Weight
    203.238
  • Molecular Formula
    C9H17NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)NCCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hilberg F, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumorefficacy. Cancer Res. 2008 Jun 15;68(12):4774-82.
molnova catalog
related products
  • Methyl propyl disulf...

    Methyl propyl disulfide is a natural compound containing volatile sulfur produced in garlic and onions. Methyl propyl disulfide displays an anticaner effect.

  • MK-886

    MK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.

  • Quazolast

    Quazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.